`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`COALITION FOR AFFORDABLE DRUGS X LLC,
`
`Petitioner,
`
`ANACOR PHARMACEUTICALS, INC.,
`
`Patent Owner.
`
`Case No. IPR2015-01776
`
`Patent No. 7,582,621
`
`
`
`PATENT OWNER ANACOR PHARMACEUTICALS, INC.’S
`
`MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`DC: 5816175—1
`
`
`
`Docket No. 0369140005-US01
`
`IPR2015-01776
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Anacor Pharmaceuticals, Inc.
`
`submits the following Mandatory Notices. In accordance with 37 C.F.R.
`
`§ 42.8(a)(2), these Mandatory Notices are being timely filed within 21 days of
`
`service of the petition.
`
`A.
`
`Real Party-In-Interest Under 37 C.F.R. § 42.8(b)(1)
`
`The real party-in-interest is Anacor Pharmaceuticals, Inc.
`
`B.
`
`Related Matters Under 37 C.F.R. § 42.8(b)(2)
`
`There are no related proceedings involving U.S. Patent No. 7,582,621 (“the
`
`‘621 Patent”).
`
`C.
`
`Lead and Back-Up Counsel Under 37 C.F.R. § 42.8(b)(3)
`
`Lead Counsel
`
`Andrea G. Reister (Reg. No. 36,253)
`areister@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202)662-5141
`Fax: (202) 778-5141
`
`Back-up Counsel
`Enrique D. Longton (Reg. No. 47,304)
`elongton@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202)662-5108
`Fax: (202) 778-5108
`
`D.
`
`Service Information Under 37 C.F.R. § 42.8(b)(4)
`
`Service information for lead and back—up counsel is provided in the
`
`designation of lead and back—up counsel, above. Service of any documents via hand-
`
`delivery may be made at the postal mailing address of the respective lead and back-
`
`up counsel designated above. Patent Owner Anacor Pharmaceuticals, Inc. consents
`
`
`
`Docket No. 0369140005-US01
`
`IPR2015-01776
`
`to electronic service by email at the above listed email addresses of Lead and Back-
`
`Up Counsel.
`
`E.
`
`Power of Attorney
`
`A Power of Attorney to transact all business in the United States Patent &
`
`Trademark Office (“USPTO”) in connection with the above—referenced Inter
`
`Partes Review from Patent Owner Anacor Pharmaceuticals, Inc. to Covington &
`
`Burling LLP (Customer No. 26853) is being filed concurrently with these
`
`Mandatory Notices. The Power of Attorney is accompanied by a Statement Under
`
`37 C.F.R. § 3.73(b), executed by the Patent Owner.
`
`Date: September 2, 2015
`
`Respectfully submitted,
`
`
`
`Andrea G. Reist
`
`Registration No. 36,253
`Enrique D. Longton
`Registration No. 47,304
`COVINGTON & BURLING LLP
`
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 2nd day of September 2015,
`
`the foregoing Patent Owner Anacor Pharmaceuticals, lnc.’s Mandatory Notices
`
`Under 37 C.F.R. § 42.8 was served by FedEx, a means at least as fast and reliable as
`
`Priority Mail Express®, on the following counsel of record for petitioner.
`
`Jeffrey D. Blake
`Merchant & Gould PC
`
`191 Peachtree Street NE, Suite 4300
`
`Atlanta, GA 30303
`
`Kathleen E. Ott
`
`Merchant & Gould PC
`
`1801 California Street, Suite 3300
`
`Denver, CO 80202
`
`Date: September 2, 2015
`
`Registration No.: 36,25